Nonspecific therapy of asthma with gold preparation and insulin.
Nonspecific therapy of asthma with Solganal and insulin showed excellent results in more than 80% of the patients, in which 50% or more recovered from asthma completely. Over all, recovered condition lasted for a long period of time. Solganal-treated patients showed resistance to acetylcholine provocation tests, good results in Tromp's water bath tests, and decreases in intensity of itching and erythema of P. K. reaction and of those caused by intracutaneous histamine injection. Animal experiments investigating damage to the liver, kidney and heart with Solganal showed no serious findings.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000380:Agranulocytosis / Q000209:etiology; D001249:Asthma / Q000188:drug therapy*; D006051:Aurothioglucose / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D005260:Female; D006046:Gold / Q000627:therapeutic use*; D006801:Humans; D007328:Insulin / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000209:etiology; D008107:Liver Diseases / Q000209:etiology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009206:Myocardium / Q000473:pathology; D012879:Skin Physiological Phenomena; D013696:Temperature
D007328:Insulin; D006051:Aurothioglucose; D006046:Gold